Emergency Medicine · Pilot preview
A Delayed Overdose Presentation
Clinical decision-making · Emergency toxicology
Start timely acetylcysteine, monitor treatment safely and use clinical endpoints to determine treatment duration.
Your five teaching phases
- 1. Initial Assessment20 pts
Identify immediate threats and obtain a focused assessment
- 2. Diagnostic Strategy25 pts
Explain the differential and select time-sensitive investigations
- 3. Treatment25 pts
Deliver and justify patient-specific emergency treatment
- 4. Reassessment & Escalation20 pts
Respond to the new deterioration and confirm treatment response
- 5. Disposition & Handoff10 pts
Arrange definitive care and communicate ongoing risks
Speak or type your answers to the examiner, then review your saved feedback.
Content sources
- FDA Acetadote label, revised July 2025, sections 2.1–2.6 and 5.1
- ACMT acetylcysteine duration practice statement, January 2026
- World Allergy Organization anaphylaxis guidance, 2020
Original educational scenario. Source check: October 18, 2026. No official ABEM scoring or exam outcome prediction.
Initial patient chart
Jordan M., 24M
Intentional acetaminophen ingestion about nine hours ago
60 kg · Reported 20 g ingestion · Level pending
- BP
- 118/72 mmHg
- HR
- 94/min
- RR
- 16/min
- SpO₂
- 99% room air
- Weight
- 60 kg
- Jordan M., 24, weighs 60 kg. He reports taking forty 500 mg immediate-release acetaminophen tablets at one time about nine hours ago after an argument. He has nausea and has vomited twice. BP 118/72, HR 94, RR 16, SpO2 99% room air. He is awake and cooperative. No known liver disease, acetylcysteine reaction, alcohol dependence, anticoagulant use or other stated ingestion. The acetaminophen level, liver tests and INR have been sent but are not yet back. He has a patent IV and has received no antidote. Poison control and mental-health support are available.
Content reviewed: 2026-10-18